Аctual aspects of migraines preventive pharmacotherapy

Headaches are one of the most common causes of disability worldwide, with migraines coming to the fore. A new and promising preventive strategy to combat migraine is drugs from the group of monoclonal antibodies to calcitonin-a gene-related peptide. High efficacy, good tolerability, and the ability to increase patient compliance increase the interest of specialists in these drugs. A potentially significant reduction in the economic burden on society and healthcare also plays an important role as a significant impact on improving the quality of life of patients. Despite the prospects of using these drugs for the prevention of migraine headaches, not all aspects related to this have been fully considered and resolved to date.